Last reviewed 2026-04-22 · How we verify

Cellular Matrix / A-CP-HA Kit

A cellular matrix product combining autologous cells with hyaluronic acid to promote tissue regeneration and repair.

A cellular matrix product combining autologous cells with hyaluronic acid to promote tissue regeneration and repair. Used for Tissue regeneration and repair (specific indications not publicly detailed).

At a glance

Mechanism of action

The A-CP-HA Kit is a regenerative medicine product that uses autologous cellular components (likely adipose-derived or bone marrow-derived cells) combined with hyaluronic acid as a scaffold matrix. This combination aims to facilitate tissue repair, reduce inflammation, and promote healing through cell-based and biomaterial-mediated mechanisms in damaged or degenerative tissues.

Approved indications

• Tissue regeneration and repair (specific indications not publicly detailed)

Common side effects

No common side effects on file.

Key clinical trials

• Efficacy of the Use of Cellular Matrix/ A-CP-HA Kit (PHASE4)
• Efficacy of Hyaluronic Acid and Platelet-rich Plasma Combination in Knee Osteoarthritis (PHASE4)
• Clinical Investigation to Compare the Safety and Efficacy of Cellular Matrix to Those of Ostenil® Plus and to Those of PRP Only (NA)
• Cellular Matrix Device for the Treatment of Mild to Moderate Knee Osteoarthritis (NA)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

• Cellular Matrix / A-CP-HA Kit CI brief — competitive landscape report
• Cellular Matrix / A-CP-HA Kit updates RSS · CI watch RSS
• Fundación Santiago Dexeus Font portfolio CI